Aragen Life Sciences files DRHP for an ₹800 crore IPO to fund debt repayment and capital expenditure.

Aragen Life Sciences seeks to raise ₹800 crore through an IPO, filing draft papers with SEBI for a fresh issue and equity sale.

Aragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repayment, capacity expansion and equipment…